Company intelligence / Profile preview

Enko

Mystic, Connecticut, United States

Ownership: Private
Employees: ~72
Development stage: Other

Overview

Enko develops small‑molecule crop protection products (herbicides, insecticides, fungicides and nematicides) discovered via its ENKOMPASS DNA‑encoded library and AI/ML platform; it reports a leading herbicide candidate that outperformed glyphosate in field trials using 13‑fold less product and has over 40 novel, active pipeline programs, but no commercial products yet.[2][3][4]

Therapeutic areas: Other
Modalities: Small molecule
Industry: Agriculture & AgTech

Partnerships

Bill & Melinda Gates FoundationSyngentaBayerNufarmWorld Economic Forum (Tech Pioneer / Global Innovator network partner)

Beyond the preview

Go deeper on Enko.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enko.

Explore the full profile